分享:
分享到微信朋友圈
X
综述
磁共振弹性成像在肝纤维化定量诊断与分期中的研究进展
赵俊苹 李红 刘昊沅 李娜 马会浩

Cite this article as: Zhao JP, Li H, Liu HY, et al. Research progress of magnetic resonance elastography in the quantitative diagnosis and staging of liver fibrosis[J]. Chin J Magn Reson Imaging, 2021, 12(12): 112-114, 117.本文引用格式:赵俊苹, 李红, 刘昊沅, 等. 磁共振弹性成像在肝纤维化定量诊断与分期中的研究进展[J]. 磁共振成像, 2021, 12(12): 112-114, 117. DOI:10.12015/issn.1674-8034.2021.12.027.


[摘要] 肝纤维化(liver fibrosis,LF)是指肝脏细胞外基质尤其是胶原纤维的异常积累,LF不加干预或干预不足可进展为肝硬化甚至肝癌。早期LF组织学上是可逆的。磁共振弹性成像(magnetic resonance elastography,MRE)是一种评估组织机械特性的稳健技术,也是目前评估LF最准确的无创影像学手段。肝脏MRE的目的是在形态学可见之前尽早观察到组织学变化,为临床尽早采取干预措施防止纤维化进一步发展提供依据。随着磁共振技术的不断进步,LF无创定量诊断及分期取得了较大进展。现就MRE在LF定量诊断与分期中的研究进展予以综述。
[Abstract] Liver fibrosis (LF) refers to the abnormal accumulation of liver extracellular matrix, especially collagen fibers. LF can progress to cirrhosis or even liver cancer without intervention or insufficient intervention. Early LF is histologically reversible. Magnetic resonance elastography (MRE) is a robust technique for evaluating the mechanical properties of tissues, and it is also the most accurate non-invasive imaging method for evaluating LF. The purpose of liver MRE is to observe histological changes as early as possible before the morphology is visible, and to provide a basis for clinical interventions to prevent the further development of fibrosis as early as possible. With the continuous advancement of magnetic resonance technology, non-invasive quantitative diagnosis and staging of LF have made great progress. This article summarizes the research progress of MRE in the quantitative diagnosis and staging of LF.
[关键词] 磁共振弹性成像;肝纤维化;定量诊断;分期;研究进展
[Keywords] magnetic resonance elastography;liver fibrosis;quantitative diagnosis;staging;research progress

赵俊苹    李红 *   刘昊沅    李娜    马会浩   

三峡大学附属仁和医院放射科,宜昌 443000

李红,E-mail:1741433022@qq.com

全体作者均声明无利益冲突。


收稿日期:2021-08-19
接受日期:2021-11-09
DOI: 10.12015/issn.1674-8034.2021.12.027
本文引用格式:赵俊苹, 李红, 刘昊沅, 等. 磁共振弹性成像在肝纤维化定量诊断与分期中的研究进展[J]. 磁共振成像, 2021, 12(12): 112-114, 117. DOI:10.12015/issn.1674-8034.2021.12.027.

       肝纤维化(liver fibrosis,LF)是指肝脏细胞外基质尤其是胶原纤维的异常积累,LF不加干预可发展为肝硬化甚至肝癌。早期LF是可逆的,专家共识[1]认为Sun等[2]提出P-I-R分类可用于评估LF动态变化,在组织学上进一步明确了LF逆转的定义。磁共振弹性成像(magnetic resonance elastography,MRE)可无创评估组织机械特性,对早期LF做出有效诊断[3, 4],为临床尽早采取干预措施提供依据,减少肝硬化及肝癌的发生。现已有多个研究表明其诊断效能高于超声、CT、扩散加权成像及血清学等临床评分系统[5, 6, 7, 8, 9, 10, 11]

1 MRE在评价肝纤维化严重程度及其分期中的应用

1.1 LF分期

       肝脏损伤常以纤维化的程度和肝硬化的形成来分期,用于评估疾病进展情况,影响治疗及预后。现国内外对LF进行分期的标准有很多,较常用的是Scheuer法即根据穿刺活检后的结果分为F0期(无纤维化)、F1期(汇管区扩大)、F2期(纤维间隔形成)、F3期(纤维间隔伴小叶)、F4期(可能或肯定肝硬化)。Scheuer法虽然认识到炎症对肝纤维化的严重性,但对分期的定义尚不明确。而Sun等[2]根据纤维间隔的所占比例不同,将LF分为进展型(progressive,P)、逆转型(regressive,R)和不确定型(indeterminate,I)三类,即P-I-R分类,此分类不仅在病理学上明确了LF分期,且指出了LF逆转的定义。

1.2 MRE弹性值与LF相关性的研究

       LF所致的组织机械特性(应变、刚度和粘弹性等)改变可通过测量弹性图的肝脏硬度值(liver stiffness measurement,LSM)来显示人体组织硬度的差异,从而作为诊断LF程度的依据[12,13]

       袁鸿鹏[14]、Jayakumar等[15]分别通过自己的研究表明MRE的肝脏硬化与纤维化显著相关。Ajmera[16]团队的一项前瞻性队列研究对102例经活检证实的肝硬化患者先后进行MRE和肝活检,然后重复配对肝活检和MRE评估。结果显示在未经调整的分析中,MRE肝硬度增加15%与组织学纤维化进展的概率增加呈正相关(OR 3.56;95% CI:1.17~10.76;P=0.0248)。即使在对年龄,性别和身体质量指数进行多变量调整后,这些发现仍具有临床和统计学意义(校正后OR 3.36;95% CI:1.10~10.31;P=0.0339)。此研究表明MRE肝硬度增加15%可反映肝纤维化组织学进程,且MRE肝硬度增加15%是进展为晚期纤维化的最强预测因子(OR 4.90;95% CI:1.35~17.84;P=0.0159)。然而,此研究虽然对肝组织学的纵向变化与MRE之间的关系进行了严格的评估,但通过对快速进展期的患者进行长期随访显示,其中60%可能被肝活检错误分类,导致不能反映真正的组织学进展。另一方面,由于进展超过一个纤维化阶段的患者数量有限,使得“剂量反应”不能得到充分说明。因此,更多跨纤维化分期的进展性病例研究是值得期待的。

1.3 MRE在LF分期中的应用

       张显怡等[4]通过MRE对20名健康志愿者及57例肝活检证实为LF患者的肝脏弹性值进行分析,研究结果表明MRE对早期LF具有较高的诊断效能,其诊断LF F1~F4期的ROC曲线下面积(area under the curve,AUC)分别为0.92、0.94、0.95、0.99。Xiao等[17]的一项荟萃分析表明MRE和实时剪切波弹性成像对LF分期的诊断准确率最高,一项对100多名患者进行的前瞻性横断面研究[18]也显示MRE在识别LF (第1期或更多期)方面比瞬时弹性成像更准确。与Lefebvre等[19]的研究结果一致。

       张凯等[20]选取40例LF病例,先行MRE检查,后经肝脏穿刺病理活检确诊。其中MRE漏诊2例,2例均经活检证实为F1期,误诊1例F2期为F1期,漏诊率5.00%、误诊率2.50%,F3、F4期检查结果与活检结果一致。在Loomba等[21]的研究中也有12名患者被错误分类,其中9名活检显示为F0~F2期纤维化的患者被归类为晚期纤维化,3名F3~F4期纤维化的患者被归类为F0~F2期纤维化,MRE将晚期纤维化与F0~F2期纤维化区分开来的AUC为0.924 (P<0.0001)。虽然张凯等[20]与Loomba等[21]的研究均表明MRE对晚期纤维化的预测更加准确,但其二者的研究结果也显示出了MRE对早期LF良好的诊断效能。人体组织弹性模量在部分区域内可能存在重复情况,当正常组织和病理组织重复时会影响MRE的诊断,这也造成了张凯等[20]研究中的两例漏诊。但是总的来说,MRE对各期LF的检出都是有效的,指导临床早期干预,逆转早期LF,防止晚期LF进一步发展,这对降低肝硬化乃至肝癌的发生发展都具有重大意义。

2 MRE技术进展

2.1 设备

       在目前的肝脏MRE扫描中应用较多的是刚性塑料驱动器,这给患者的检查过程带来了不适,丁丽等[22]开发的一种柔性气动驱动器,极大地改善了患者的体验感,相比于刚性驱动器,柔性驱动器更加贴合胸壁,能够使得波的传播更加均匀,且二者获得的肝脏硬度值差异无统计学意义[23]

2.2 序列

       目前常见的MRE序列是梯度回波序列(gradient echo,GRE)、自旋回波序列(spin echo,SE)、自旋回波-平面回波序列(spin echo-echo planar imaging,SE-EPI)及平衡稳态自由进动序列。其中GRE-MRE序列是最常用的序列[24],但其容易受肝脏铁质沉积的影响[25, 26, 27],导致肝脏硬度的测量不稳定。而铁超载在慢性肝病患者中并不少见,对此,SE-EPI序列成为了更佳的选择。已有研究表明,SE-EPI对磁场的均匀性不太敏感[28,29],且该序列基于视图共享的重建策略可以避免呼吸运动伪影,这使得其在铁超载、屏气困难的患者中仍然能够准确地进行图像采集[30]

2.3 后处理技术

       目前常用的后处理方式分为二维(2D)和三维(3D),2D即选择肝脏最大层面处扫描4层图像并从两个方向上的波传播数据进行分析,此种后处理方式可能由于波的传播不完整导致肝脏硬度的测量误差[31]。而3D后处理方式可以对全肝进行扫描,实现对波的传播数据进行全面分析,并且能够消除产生干扰的纵向传播波,使得到的肝脏硬度值更加稳定、准确[32]。Loomba[30]的一项前瞻性研究也表明3D-MRE的成像模式较2D-MRE更为准确。此外,更有研究表明,将3D后处理技术与SE-EPI序列结合,不仅能增加扫描范围、提高图像信噪比及准确率,还能在肝纤维化分期诊断中显现出良好性能[32, 33, 34]。但是由于3D-MRE扫描时间长,技术要求更高,故普及率不高,但其应用前景是值得期待的[35]

2.4 ROI的勾画

       常规ROI的勾画往往是手动的,避开肝脏边缘、胆管及大血管等,取平均值作为肝脏硬度值,或者直接选取肝脏最大截面的平均值。此种手动勾画方法易受勾画者的主观影响,且对于不均匀性肝纤维化患者、LF进程不一致者等不能准确评估其纤维化分期[36]。而Rezvani[37]等提出的一种基于全肝容积的容积分割测量法可以通过分析软件对肝脏进行分段,进而提供LF硬度值的分布情况,使得LF评估更加准确、具体。此外,还有学者提出自动肝弹性计算[38,39]算法来通过自动在图像中定位肝脏,检测肝脏边缘、绘制ROI。

3 展望

       现已有多个研究表明MRE对早期LF的诊断及评估具有显著优势,这将有利于临床早期干预,降低肝硬化及肝癌的发生率。同时,MRE还可检出由肝脏病变引起的尚未见临床症状的食管静脉曲张[40,41]和门脉高压症[42]。当联合脾脏硬度一起测量的时候,肝脏硬度值似乎更加准确、稳定[43]

       此外,MRE还可用于肝脏肿瘤、炎症的特征描述。Thompson等[44]的一项初步研究显示原发性肝癌的组织病理学分级和肿瘤硬度之间可能存在关系,低分化肝细胞癌往往比高分化和中等分化肝细胞癌具有更高的硬度,且原发性肝癌早期就已有外周硬度的升高,这可能有助于早期原发性肝癌的检出。急性炎症可由于炎症细胞的募集以及炎症造成的肝脏水肿和充血导致肝包膜的实质扩张和拉伸,从而使得肝脏硬度普遍增加,而慢性炎症或亚急性炎症仅导致肝脏硬度的轻度增加(低于3 kPa)[45]。虽然目前的MRE技术很难对肝脏硬度进行量化和与纤维化分开,但这一目标有望随着MRE技术的进展在未来实现。

       总之,肝脏MRE是一个很有前景的研究领域,其技术的发展更是进一步提高了肝脏疾病诊断的准确性及特异性。

[1]
陆伦根, 尤红, 谢渭芬, 等. 肝纤维化诊断及治疗共识(2019年)[J]. 实用肝脏病杂志, 2019, 22(6): 793-803. DOI: 10.3969/j.issn.1672-5069.2019.06.006.
Lu LG, You H, Xie WF. Consensus on the diagnosis and treatment of liver fibrosis(2019)[J]. J Prac Hepatol, 2019, 22(6): 793-803. DOI: 10.3969/j.issn.1672-5069.2019.06.006.
[2]
Sun Y, Zhou J, Wang L, et al. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment[J]. Hepatology, 2017, 65(5): 1438-1450. DOI: 10.1002/hep.29009.
[3]
张清华, 杨新官, 唐艳云. 肝纤维化分期诊断中磁共振弹性成像技术的临床应用[J].影像技术, 2020, 32(3): 38-40. DOI: 10.3969/j.issn.1001-0270.2020.03.13.
Zhang QH, Yang XG, Tang YY. Clinical Application of Magnetic Resonance Elastography in the Diagnosis of Liver Fibrosis[J]. Image Technology, 2020, 32(3): 38-40. DOI: 10.3969/j.issn.1001-0270.2020.03.13.
[4]
张显怡, 纪若云, 蔡小丽, 等. 3.0T磁共振弹性成像评价非酒精性脂肪肝及预测脂性肝炎[J].中国临床医学影像杂志, 2019, 30(12): 859-862. DOI: 10.12117/jccmi.2019.12.006.
Zhang XY, Ji RY, Cai XL, et al. 3.0 T Magnetic Resonance Elastography Evaluation of Non-alcoholic Fatty Liver and Prediction of Fatty Hepatitis[J]. Journal of China Medical Imaging, 2019, 30(12): 859-862. DOI: 10.12117/jccmi.2019.12.006.
[5]
于晓娟. 核磁共振弹性成像技术在肝纤维化诊断中的应用价值[J]. 中华灾害救援医学, 2017, 5(12): 698-701. DOI: 10.13919/j.issn.2095-6274.2017.12.009.
Yu XJ. The value of magnetic resonance elastography in the diagnosis of hepatic fibrosis[J]. Chinese Journal of Disaster Medicine, 2017, 5(12): 698-701. DOI: 10.13919/j.issn.2095-6274.2017.12.009.
[6]
Dyvorne HA, Jajamovich GH, Bane O, et al. Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection[J]. Liver Int, 2016, 36(5): 659-666. DOI: 10.1111/liv.13058.
[7]
沈萍. 磁共振弹性成像与超声瞬时弹性成像、扩散加权成像诊断肝纤维化的对照研究[D]. 苏州大学, 2018.
Shen P. Comparative study of magnetic resonance elastography, ultrasonic transient elastography, and diffusion-weighted imaging in the diagnosis of liver fibrosis[D]. Soochow University, 2018.
[8]
Imajo K, Kessoku T, Honda Y, et al. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography[J]. Gastroenterology, 2016, 150(3): 626-637. DOI: 10.1053/j.gastro.2015.11.048.
[9]
Cui J, Ang B, Haufe W, et al. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study[J]. Aliment Pharmacol Ther, 2015, 41(12): 1271-1280. DOI: 10.1111/apt.13196.
[10]
王敏, 石喻, 郭启勇. 磁共振弹性成像评价肝脏疾病的研究进展[J]. 中国医科大学学报, 2019, 48(9): 841-844. DOI: 10.12007/j.issn.0258-4646.2019.09.016.
Wang M, Shi Y, Guo QY. Research Progress of Magnetic Resonance Elastography for Evaluating Liver Diseases[J].Journal of China Medical University, 2019, 48(9): 841-844. DOI: 10.12007/j.issn.0258-4646.2019.09.016.
[11]
王晗, 王宇, 马红. 磁共振弹性成像在慢性肝病无创评估中的应用[J]. 临床肝胆病杂志, 2019, 35(5): 1143-1147. DOI: 10.3969/j.issn.1001-5256.2019.05.048.
Wang H, Wang Y, Ma H. Clinical application of magnetic resonance elastography in noninvasive diagnosis of chronic liver diseases[J]. J Clin Hepatol, 2019, 35(5): 1143-1147. DOI: 10.3969/j.issn.1001-5256.2019.05.048.
[12]
Akkaya HE, Erden A, Kuru Öz D, et al. Magnetic resonance elastography: basic principles, technique, and clinical applications in the liver[J]. Diagn Interv Radiol, 2018, 24(6): 328-335. DOI: 10.5152/dir.2018.18186.
[13]
Petitclerc L, Sebastiani G, Gilbert G, et al. Liver fibrosis: Review of current imaging and MRI quantification techniques[J]. J Magn Reson Imaging, 2017, 45(5): 1276-1295. DOI: 10.1002/jmri.25550.
[14]
袁鸿鹏. 磁共振弹性成像技术在肝纤维化分期诊断中的应用[J]. 临床合理用药杂志, 2019, 12(16): 120-121. DOI: 10.15887/j.cnki.13-1389/r.2019.16.069.
Yuan HP. Application of Magnetic Resonance Elastography in the Staging and Diagnosis of Liver Fibrosis[J]. Chin J of Clinical Rational Drug Use, 2019, 12(16): 120-121. DOI: 10.15887/j.cnki.13-1389/r.2019.16.069.
[15]
Jayakumar S, Middleton MS, Lawitz EJ, et al. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib[J]. J Hepatol, 2019, 70(1): 133-141. DOI: 10.1016/j.jhep.2018.09.024.
[16]
Ajmera VH, Liu A, Singh S, et al. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease[J]. Hepatology, 2020, 71(3): 849-860. DOI: 10.1002/hep.30974.
[17]
Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis[J]. Hepatology, 2017, 66(5): 1486-1501. DOI: 10.1002/hep.29302.
[18]
Park CC, Nguyen P, Hernandez C, et al. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease[J]. Gastroenterology, 2017, 152(3): 598-607. DOI: 10.1053/j.gastro.2016.10.026.
[19]
Lefebvre T, Wartelle-Bladou C, Wong P, et al. Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis[J]. Eur Radiol, 2019, 29(12): 6477-6488. DOI: 10.1007/s00330-019-06331-4.
[20]
张凯, 邹丽秋, 高慧, 等. 探讨核磁共振弹性成像技术在肝纤维化分期诊断中的应用效果[J].现代医用影像学, 2020, 29(7): 1195-1197, 1201.
Zhang K, Zou LQ, Gao H. To explore the application effect of MRI elastography in the staging diagnosis of liver fibrosis[J]. Modern Med Imaging, 2020, 29(7): 1195-1197, 1201.
[21]
Loomba R, Wolfson T, Ang B, et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study[J]. Hepatology, 2014, 60(6): 1920-1928. DOI: 10.1002/hep.27362.
[22]
丁丽. 基于磁流变弹性体的柔性传感器件的研制及其性能研究[D]. 中国科学技术大学, 2020. DOI: 10.27517/d.cnki.gzkju.2020.000159.
Ding L. The development and performance of flexible sensor parts based on magnetic rheumometers[D]. China University of Science and Technology, 2020. DOI: 10.27517/d.cnki.gzkju.2020.000159.
[23]
Wang K, Manning P, Szeverenyi N, et al. Repeatability and reproducibility of 2D and 3D hepatic MR elastography with rigid and flexible drivers at end-expiration and end-inspiration in healthy volunteers[J]. Abdom Radiol (NY), 2017, 42(12): 2843-2854. DOI: 10.1007/s00261-017-1206-4.
[24]
Cunha GM, Glaser KJ, Bergman A, et al. Feasibility and agreement of stiffness measurements using gradient-echo and spin-echo MR elastography sequences in unselected patients undergoing liver MRI[J]. Brit J Radiol, 2018, 91(1087): 20180126. DOI: 10.1259/bjr.20180126.
[25]
Calle-Toro JS, Serai SD, Hartung EA, et al. Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease[J]. Abdom Radiol (NY), 2019, 44(3): 894-902. DOI: 10.1007/s00261-018-1884-6.
[26]
Mariappan YK, Dzyubak B, Glaser KJ, et al. Application of Modified Spin-Echo-based Sequences for Hepatic MR Elastography: Evaluation, Comparison with the Conventional Gradient-Echo Sequence, and Preliminary Clinical Experience[J]. Radiology, 2017, 282(2): 390-398. DOI: 10.1148/radiol.2016160153.
[27]
Serai SD, Dillman JR, Trout AT. Spin-echo Echo-planar Imaging MR Elastography versus Gradient-echo MR Elastography for Assessment of Liver Stiffness in Children and Y oung Adults Suspected of Having Liver Disease[J]. Radiology, 2017, 282(3): 761-770. DOI: 10.1148/radiol.2016160589.
[28]
Rohit L, Jeffrey C, Tanya W, et al. Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in NAFLD:a prospective study[J]. Am J Gastroenterol, 2016, 111(7): 986-994. DOI: 10.1038/ajg.2016.65.
[29]
Serai SD, Trout AT. Can MR elastography be used to measure liver stiffness in patients with iron overload?[J]. Abdom Radiol (NY), 2019, 44(1): 104-109. DOI: 10.1007/s00261-018-1723-9.
[30]
Loomba R, Cui J, Wolfson T, et al. Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in NAFLD: a prospective study[J]. Am J Gastroenterol, 2016, 111(7): 986-994. DOI: 10.1038/ajg.2016.65.
[31]
Tang A, Cloutier G, Szeverenyi NM, et al. Ultrasound elastography and MR elastography for assessing liver fibrosis: part 1, principles and techniques[J]. AJR Am J Roentgenol, 2015, 205(1): 22-32. DOI: 10.2214/AJR.15.14552.
[32]
Hoodeshenas S, Yin M, Venkatesh SK. Magnetic resonance elastography of liver[J]. Magn Reson Imaging, 2018, 27(5): 319-333. DOI: 10.1097/RMR.0000000000000177.
[33]
Yoon JH, Lee JM, Lee KB, et al. Comparison of monoexponential, intravoxel incoherent motion diffusion-weighted imaging and diffusion kurtosis imaging for assessment of hepatic fibrosis[J]. Acta Radiol, 2019, 60(12): 1593-1601. DOI: 10.1177/0284185119840219.
[34]
Mathew RP, Venkatesh SK. Imaging of hepatic fibrosis[J]. Current Gastroenterol Rep, 2018, 20(10): 1-10. DOI: 10.1007/s11894-018-0652-7.
[35]
Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease[J]. Gastroenterology, 2019, 156(5): 1264-1281. DOI: 10.1053/j.gastro.2018.12.036.
[36]
Cogneau A, Cho H, Lucidarme O, et al. Do regions of interest location and type influence liver stiffness measurement using magnetic resonance elastography?[J]. Diagn Interv Imag, 2019, 100(6): 363-370. DOI: 10.1016/j.diii.2019.01.005.
[37]
Rezvani HR, Khoshpouri P, Ghadimi M, et al. Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography[J]. Eur Radiol, 2020, 30(3): 1609-1615. DOI: 10.1007/s00330-019-06478-0.
[38]
Fenstad ER, Dzyubak B, Oh JK, et al. Evaluation of liver stiffness with magnetic resonance elastography in patients with constrictive pericarditis :preliminary findings[J]. J Magn Reson Imaging,2016, 44(1): 81-88. DOI: 10.1002/jmri.25126.
[39]
Eaton JE, Dzyubak B, Venkatesh SK, et al. Performanceof magnetic resonance elastography in primary sclerosing cholangitis[J]. J Gastroenterol Hepatol, 2016, 31(6): 1184-1190. DOI: 10.1111/jgh.13263.
[40]
Abe H, Midorikawa Y, Matsumoto N, et al. Prediction of esophageal varices by liver and spleen MR elastography[J]. Eur Radiol, 2019, 29(12): 6611-6619. DOI: 10.1007/s00330-019-06230-8.
[41]
Hoffman DH, Ayoola A, Nickel D, et al. MR elastography, T1 and T2 relaxometry of liver: role in noninvasive assessment of liver function and portal hypertension[J]. Abdom Radiol (NY), 2020, 45(9): 2680-2687. DOI: 10.1007/s00261-020-02432-7.
[42]
Wagner M, Hectors S, Bane O, et al. Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: Preliminary results[J]. J Magn Reson Imaging, 2018, 48(4): 1091-1103. DOI: 10.1002/jmri.26026.
[43]
Cheng YW, Chang YC, Chen YL, et al. Feasibility of measuring spleen stiffness with MR elastography and splenic volume to predict hepatic fibrosis stage[J]. PLoS One, 2019, 14(5): e0217876. DOI: 10.1371/journal.pone.0217876.
[44]
Thompson SM, Wang J, Chandan VS, et al. MR elastography of hepatocellular carcinoma: Correlation of tumor stiffness with histopathology features-Preliminary findings[J]. Magn Reson Imaging, 2017, 37: 41-45. DOI: 10.1016/j.mri.2016.11.005.
[45]
Venkatesh SK, Wells ML, Miller FH, et al. Magnetic resonance elastography: beyond liver fibrosis-a case-based pictorial review[J]. Abdom Radiol (NY), 2018, 43(7): 1590-1611. DOI: 10.1007/s00261-017-1383-1.

上一篇 磁共振体素内不相干运动成像在直肠癌临床诊疗中的应用进展
下一篇 中枢神经系统华勒氏变性的扩散磁共振成像研究进展
  
诚聘英才 | 广告合作 | 免责声明 | 版权声明
联系电话:010-67113815
京ICP备19028836号-2